FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
What Are the MDMA Risks of Therapy for PTSD?news2024-06-04T22:12:47+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Legal Weed Is Coming. It’s Time to Come Up With Some Rules.news2024-05-20T15:30:43+00:00May 20th, 2024|The New York Times|
Lo que hay que saber sobre la ibogaínanews2024-03-09T10:02:51+00:00March 9th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
Telehealth Prescription Rules May Change Soon. Here’s What to Know.news2023-04-05T09:00:19+00:00April 5th, 2023|The New York Times|
